How Much Did POC Pharma Raise?
Funding & Key Investors

POC Pharma has secured $4.5M in total funding, with its most recent capital infusion amounting to $4.5M. This major strategic investment underscores the company's significant progress and potential within the enterprise-level funding landscape. The recent financing round, dated April 28, 2021, signifies a pivotal moment for the SaaS provider.

What is POC Pharma?

POC Pharma
SoftwareCustomer Engagement Platforms

POC Pharma is a Hong Kong-based SaaS company established in 2019, dedicated to enhancing stakeholder engagement within the Pharmacy Channel. The platform offers sophisticated solutions for customized customer engagement, personalized treatment recommendations, and streamlined multichannel commercialization strategies. Its focus on leveraging technology to optimize pharmaceutical commercialization positions it as a key player in the digital health and SaaS sectors.

How much funding has POC Pharma raised?

POC Pharma has raised a total of $4.5M across 1 funding round:

2021

Angel/Seed

$4.5M

Angel/Seed (2021): $4.5M with participation from Picus Capital, 500 Global, FEBE Ventures, FJ Labs, and Goat Capital

Key Investors in POC Pharma

Picus Capital

Picus Capital is an investor that participated in POC Pharma's funding round. Further details on their specific investment focus are not provided in the input data.

500 Global

500 Global, a venture capital firm founded in 2010 and headquartered in Mountain View and San Francisco, California, invests in companies across the globe. They participated in POC Pharma's funding round.

FEBE Ventures

FEBE Ventures is a global seed-focused venture capital firm founded by experienced ex-founders, providing financial investment and support to startups. They have invested in over 200 startups across various sectors and emerging markets, and were a backer of POC Pharma.

What's next for POC Pharma?

The substantial enterprise-level funding and recent strategic investment indicate that POC Pharma is poised for significant scaling and market expansion. This capital infusion will likely fuel further development of its customer engagement and commercialization tools, potentially enabling the company to penetrate new markets or enhance its existing offerings. The company's trajectory suggests a focus on solidifying its position as a leader in pharmacy channel SaaS solutions, with future growth likely centered on technological innovation and strategic partnerships.

See full POC Pharma company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Financial SoftwareSoftwareSupply Chain Management (SCM) Software
Financial SoftwareSoftwareBusiness ServicesSoftware Testing
Engineering SoftwareSoftware
Legal SolutionsSoftware

Frequently Asked Questions Regarding POC Pharma Financial Insights

What are the most recent funding rounds that POC Pharma has completed, and what were the funding rounds?
POC Pharma has recently completed 1 funding rounds: Angel/Seed on Apr 28, 2021.
What is the total amount of funding POC Pharma has raised to date?
POC Pharma has raised a total of $4.5M in funding to date.
How many funding rounds has POC Pharma completed?
POC Pharma has completed 1 funding rounds.
How much funding did POC Pharma raise in its most recent funding round?
POC Pharma raised $4.5M in its most recent funding round.
Who are the lead investors in POC Pharma's latest funding round?
The lead investor in POC Pharma's latest funding round was Picus Capital. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in POC Pharma's history?
The largest funding round in POC Pharma's history was $4.5M.
See more information about POC Pharma